Evidence map›Paper›PMID 29796622›Full record

Trial reportThe Journal of nutrition2018

Gestational Age and Maternal Serum 25-hydroxyvitamin D Concentration Interact to Affect the 24,25-dihydroxyvitamin D Concentration in Pregnant Adolescents.

Cora M Best, Eva K Pressman, Ruth Anne Queenan, Elizabeth Cooper, Françoise Vermeylen, Kimberly O O'Brien

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The Journal of nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01815047 (Vitamin D Status Impacts Inflammation and Risk of Infections During Pregnancy), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01815047 nacompletednot on this map

Vitamin D Status Impacts Inflammation and Risk of Infections During Pregnancy

TypeinterventionalSponsorCornell UniversityRan2012 to 2019Enrolled85ConditionsInflammation, InfectionArmsVitamin D3 Supplementation
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Regimens of vitamin D supplementation for women during pregnancy.The Cochrane database of systematic reviews · 2019
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cora M BestDivision of Nutritional Sciences, Cornell University, Ithaca, NY.
Eva K PressmanDepartment of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Ruth Anne QueenanDepartment of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Elizabeth CooperDepartment of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Françoise VermeylenCornell Statistical Consulting Unit, Cornell University, Ithaca, NY.
Kimberly O O'BrienDivision of Nutritional Sciences, Cornell University, Ithaca, NY.
Cornell University · USUniversity of Rochester · US

Funding

NUTRITION TRAININGT32DK007158 · NIDDK · CORNELL UNIVERSITY ITHACA · PI PATRICIA A CASSANO, Julia L. Finkelstein · 1986 to 2026
$7.4M
NIDDK NIH HHS T32 DK007158
6 · The paper itself

Abstract

Background: Interpretation of serum vitamin D biomarkers across pregnancy is complex due to limited understanding of pregnancy adaptations in vitamin D metabolism. During pregnancy, both gestational age and serum 25-hydroxyvitamin D [25(OH)D] concentrations may influence the concentrations of 1,25-dihydroxyvitamin D [1,25(OH)2D], 24,25-dihydroxyvitamin D [24,25(OH)2D], and parathyroid hormone (PTH). Objective: We aimed to identify predictors of change in serum 25(OH)D across gestation in pregnant adolescents and to assess the contribution made by cholecalciferol (vitamin D3) supplementation. We sought to determine whether gestational age and 25(OH)D concentration interacted to affect serum 1,25(OH)2D, 24,25(OH)2D, or PTH. Methods: Pregnant adolescents (n = 78, 59% African American, mean ± SD age: 17 ± 1 y) living in Rochester, NY (latitude 43°N) were supplemented with 200 IU or 2000 IU vitamin D3/d and allowed to continue their daily prenatal supplement that contained 400 IU vitamin D3. Serum was collected at study entry (18 ± 5 wk of gestation), halfway through study participation, and at delivery (40 ± 2 wk). Serum concentrations of the biochemical markers were modeled with linear mixed-effects regression models. Results: Vitamin D3 supplement intake and season of delivery determined change in 25(OH)D across pregnancy. Fall-winter delivery was associated with a decline in 25(OH)D unless vitamin D3 supplement intake was >872 IU/d. The interaction of gestational age and 25(OH)D affected 24,25(OH)2D concentrations. For a given 25(OH)D concentration, model-predicted serum 24,25(OH)2D increased across gestation except when 25(OH)D was <13 ng/mL. Below this threshold, 24,25(OH)2D was predicted to decline over time. Mean serum 1,25(OH)2D was elevated (>100 pg/mL) throughout the study. Conclusion: Our results suggest that when maternal serum 25(OH)D was low, its catabolism into 24,25(OH)2D decreased or remained stable as pregnancy progressed in order to maintain persistently elevated serum 1,25(OH)2D. Furthermore, in adolescents living at latitude 43°N, standard prenatal supplementation did not prevent a seasonal decline in 25(OH)D during pregnancy. This study was registered at clinicaltrials.gov as NCT01815047.

Indexed as

Gestational AgeAdolescentBiomarkersCholecalciferolDose-Response Relationship, DrugFemaleHumansPregnancyVitamin D24,25-dihydroxyvitamin D25-hydroxyvitamin DBiomarkersCholecalciferolVitamin D

Identifiers

PMID29796622
PMCPMC6014295
OpenAlexW2804367756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.